Biohaven Pharmaceutical Holding Company Ltd

NYSE:BHVN   3:59:54 PM EDT
147.72
+0.11 (+0.08%)
Other Pre-Announcement

Biohaven Pharmaceutical Reports Q2 Loss Per Share $6.21

Published: 08/05/2022 11:29 GMT
Biohaven Pharmaceutical Holding Company Ltd (BHVN) - Reports (not Sees) Q2 Loss per Share $6.21.
Biohaven Reports Second Quarter 2022 Financial Results and Reports Recent Business Developments.
Net Product Revenue Was $194.0 Million for Three Months Ended June 30, 2022.
Qtrly Loss per Share $6.21.
Q2 Earnings per Share View $-2.58, Revenue View $212.1 Million -- Refinitiv Ibes Data (analyst estimates).